semaglutide manufacturer in india Type-2 Diabetes Sun Pharma, Dr Reddy's, Glenmark

2026 Mar 18

STRIDE: Semaglutide in PAD Elsewhere, attendees also heard the findings of a new analysis from the STRIDE trial demonstrating the potential vascular benefits of semaglutide in patients with peripheral artery disease (PAD) and type 2 diabetes, including improvement in symptoms, quality of life, and disease progression in patients

"And honestly, we've been losing." The emergence of GLP-1 medicationsoriginally developed for human diabetes and later found to cause significant weight lossopened a new frontier

Among the GLP-1 RAs, evidence of CV benefit is strongest for liraglutide, favorable for semaglutide, and less certain for exenatide

Can anyone take oral semaglutide